Sign in
4

Changes in Ownership

Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-23-006530

EVP, General Counsel sold 19,402 shares at $8.94 ($173,454)

  • EVP, General Counsel acquired 204,810 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Robertson Stephen P. EVP, General Counsel 2023-03-02 Grant or award +204,810 322,766 D
Robertson Stephen P. EVP, General Counsel 2023-03-02 Sale −19,402 $8.94 $173,454 303,364 D
Open-market sales · 19,402 sh · avg $8.94 · $173,454
Loading xslF345X03/wf-form4_167813813532555.xml…